Women’s values in contraceptive choice: a systematic review of relevant attributes included in decision aids by Kirk D Wyatt et al.
Wyatt et al. BMC Women's Health 2014, 14:28
http://www.biomedcentral.com/1472-6874/14/28RESEARCH ARTICLE Open AccessWomen’s values in contraceptive choice: a
systematic review of relevant attributes included
in decision aids
Kirk D Wyatt1,2, Ryan T Anderson1,2, Douglas Creedon3, Victor M Montori2,4,5, John Bachman6, Patricia Erwin7
and Annie LeBlanc2,5,8*Abstract
Background: Women can choose from a range of contraceptive methods that differ in important ways. Inadequate
decision support may lead them to select a method that poorly fits their circumstances, leading to dissatisfaction,
misuse, or nonuse. Decision support interventions, such as decision aids, may help women choose a method of
contraception that best fits their personal circumstances. To guide future decision aid development, we aim to
summarize the attributes of contraceptive methods included in available decision aids as well as surveys and
interviews of women actively choosing a contraceptive method.
Methods: We conducted a systematic review to identify attributes of contraceptive methods that may be
important to women when engaging in this decision making process. We performed a database search of
MEDLINE/PubMed, Ovid EMBASE, OVID CENTRAL, Ovid PsycInfo, EBSCO CINAHL, Popline, and Scopus from 1985
until 2013 to identify decision aids, structured interviews and questionnaires reporting attributes of contraceptive
options that are of importance to women. A free-text internet search was also performed to identify additional
decision support tools. All articles and tools were reviewed in duplicate for inclusion, and a summary list of
attributes was compiled.
Results: We included 20 surveys, 1 semistructured interview report and 19 decision aids, reporting 32 unique
attributes. While some attributes were consistently included in surveys/interviews and decision aids, several were
included more often in decision aids as opposed to surveys/interviews (e.g., STI prevention, noncontraceptive
benefits, how the method is used, requirement of a healthcare provider), and vice versa (e.g., a woman’s vicarious
experience with contraceptive methods). Key attributes mentioned in both surveys/interviews and decision aids
include efficacy (29 total mentioned) and side effects/health risks (28 total mentioned). While a limited number of
decision support tools were formally evaluated, many were not rigorously studied.
Conclusions: Many attributes were identified as potentially important to women choosing a method of
contraception, but these were inconsistently included in the reviewed resources. Formal evaluation of decision
support tools for contraceptive choice and involvement of users in the development process may lead to more
user-centered design and implementation.
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Contraceptive use is widespread in the United States,
with 99% of sexually active women in the United States
having used a form of contraception at some time [1].
Currently, 62% of all women of childbearing age use
some form of contraception. Use is inconsistent, how-
ever, and 11% of women who are at risk of unintended
pregnancy are not using any form of contraception [1].
Moreover, nearly half (49%) of all pregnancies in the
United States are unintended [2]. The finding that 95%
of these unintended pregnancies are due to inconsistent
and non-use of contraceptives despite their wide avail-
ability indicates that the problem is not the efficacy of
contraception—the problem is whether people will use
contraception and use it consistently [3].
When choosing a method of contraception, women
are faced with a wide range of options and various attri-
butes associated with these options to consider. When
faced with complex decisions in the absence of adequate
decision support, some women inevitably choose a
method that does not optimally fit their personal cir-
cumstances. This poor “fit” is reflected in the fact that
40% of married women and 61% of unmarried women in
the United States change contraceptive methods within
a two-year period [4]. Some of this method switching
may also be attributed to women’s evolving needs and
highlights that women frequently re-visit this decision.
Shared decision making (SDM) is a process whereby a
person makes decisions with a healthcare professional,
considering the available evidence regarding options be-
ing considered, in the context of the person’s needs,
values and preferences [5]. Increasingly, women are re-
questing the SDM approach in contraceptive choice [6].
Decision aids (DAs) can facilitate SDM by presenting
complex and multifaceted attributes of these options in
ways that are both evidence-based and easy for users to
understand [7]. Because of the complexity of options and
attributes about each to be considered, DAs may usefully
facilitate the choice of contraception methods [8].
In order to understand if existing tools fit the needs of
users, and to inform the development of future DAs for
women considering contraception, we systematically
assessed whether the attributes of contraceptive options
that women are considering align with those reported in
available contraception decision support tools.
Methods
A librarian experienced with performing systematic re-
views related to SDM (P.E.) performed a literature
search through MEDLINE/PubMed, Ovid EMBASE,
OVID CENTRAL, Ovid PsycInfo, EBSCO CINAHL,
Popline, and Scopus, from 1985 until January 2013. The
strategy comprised subject headings and textwords de-
scribing all forms of family planning and reproductivecontrol for women. This conceptual grouping was matched
with methods to communicate with the person and facili-
tate informed choice, such as DAs, person education tech-
niques, and pamphlets. Sample search strategies are
included in Additional file 1. Authors were not contacted
to identify additional studies.
Eligible studies were experimental or observational
studies of any design published in English with or with-
out comparator groups and targeting any population.
Given the nature of our question, qualitative studies
were included. Reports should describe the application
of a DA or other method (e.g., survey, semi-structured
interview) intended to facilitate sharing of information
during a clinical encounter or in the setting of an actual
decision about contraception (whether during or outside
of the clinical encounter) and should report attributes
relevant to a woman’s choice of contraception. Decision
aids were not required to meet specific criteria in order
to be included. Surveys of women not actively consider-
ing contraceptives were not eligible for inclusion. Studies
were included regardless of reported outcomes.
In an effort to be as inclusive as possible, we also con-
ducted free-text internet searches to identify online DAs for
contraception that may not have been published in the
database-indexed literature or formally studied. Inclusion of
these resources was based on consensus of two reviewers.
Analysis
All attributes included in included resources were ex-
tracted and added to a master list. The master list was
then examined for related attributes that could be classi-
fied together under a single category, and a reclassifica-
tion round was used to confirm the stability of these
categories. The main reviewer (K.D.W) and a second re-
viewer (A.L.) met at each stage to achieve consensus on
attribute identification and classification; also, a 10%
sample was extracted in duplicate by an independent re-
viewer to ensure the reproducibility of the process. Ex-
traction was not confirmed with study/tool authors.
Results
Search results
Figure 1 reveals the flow of our search and selection
process resulting in 28 articles for inclusion (10 surveys,
1 semi-structured interview, 7 DAs, 10 DA + survey), of
which two (one DA only and one DA + survey) did not
report the attributes sufficiently for extraction of mean-
ingful data to be performed. Common reasons for arti-
cles not being included were not reporting on a method
of patient engagement and not being used in the context
of an actual decision regarding contraception. Five arti-
cles reported on the World Health Organization (WHO)
Decision-making Tool for Family Planning Clients and
Providers (DMT) and were considered together. Eight
Potentially-relevant articles screened
(n=1,237)
Articles identified by at least 
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Figure 1 Flow diagram.
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cluded resources (19 unique decision aids, 20 surveys,
and 1 semistructured interview) from which we could
extract meaningful data. These surveys, interview, and
decision aids have been used in the United States, Europe
and the developing world.
Of the studies reporting decision aids, only five were ran-
domized trials. One study utilized a pseudo-randomized
design, six were quazi-experimental (usually comparing
pre- and post-implementation of intervention), and five
evaluated the decision aid with a questionnaire after use
(with or without pre-intervention questionnaire). Details
on the reported processes for developing included deci-
sion aids are reported in Additional file 2.
Overarching categories
After creating and reviewing the master list of attributes
from the included resources, 32 unique attributes were
identified. Each of these could be classified in one of four
overarching categories, which were chosen by the authors
after review of the master list: Mechanistic, Method Effect,
Social/Normative, Practical (Table 2). An earnest effort
was made to avoid redundant attributes and classify each
attribute under only one overarching category, realizingthat attributes and overarching categories are not mutually
exclusive. Mechanistic captured aspects of how the
method is used, including some implied considerations,
such as whether the method required use of a needle or
hormones and whether the method could be used post-
coital (i.e., used after unprotected intercourse to prevent
pregnancy). Method effect included the method’s efficacy
for pregnancy prevention and noncontraceptive effects,
including side effects, health risks, health benefits, and
menstrual changes. Social/Normative encompassed how
internal influences—such as a person’s prior experience or
expectations—and external influences—such as vicarious
experience (i.e., a woman’s understanding of contraceptive
use as obtained through others [e.g., family and friends]
who have used the methods and shared their experience)
and partner support—impact contraceptive choice. Prac-
tical included attributes such as a person’s ability to obtain
the method and the attribute’s compatibility with their
means and sexual experiences.
Attributes included in individual resources
Figure 2 shows the number of resources that mentioned
each attribute. Because decision aids and surveys from
the same paper do not necessarily include the same
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Table 1 Characteristics of included resources (Continued)
Goldstuck
1989 [29]
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Table 2 Overarching categories and attributes influencing contraceptive choice
Attribute Included terms (similar attributes)
Mechanistic
Ease of use Effort, convenience
Probability of omission Mistake-proof, requirement of daily action
How used Instructions for use, mechanistic explanation
Frequency of use Timing, use pattern (e.g., three out of four weeks)
Return to fertility Reversibility, permanence, control over method, childbearing plans
Effect latency When method can be started, advanced planning necessary, works immediately
Foreign body phobia Comfort with genital touching/genital exam/wearing patch
Needle phobia
Use of hormones Hormone levels
Requirement of healthcare provider visit (for initiation and/or follow-up)
Post-coital Works after sex
Pre-sex preparation Action required prior to each intercourse
Method effect
Efficacy Pregnancy prevention, “perfect use”, “typical use”
Maximizing efficacy Factors reducing or maximizing efficacy, action required in case of method failure or imperfect use
STI prevention
Side effects/health risks Safety, contraindications, drug interactions (e.g., antiretrovirals), latex allergy
Noncontraceptive benefits Health benefits
Menstrual changes Bleeding, cramping
Postpartum compatibility Breastfeeding compatible
Alarm signs Reasons to return to clinic, serious side effects
Social/normative
Partner support Partner compliance/involvement/acceptability/attitudes
Prior experience Prior method use
Vicarious experience Peer experience/advice, health professional input, media, peer/family acceptability/attitudes
Expectations Perceptions or myths about methods and complications
Religions/moral considerations
Concealability Discreet, private (from partner or others)
Reputation Popularity, artificiality, naturalness
Requires parental consent
Practical
Cost (financial) Ability to pay, how cost is distributed over time
Effect on sexual pleasure Effect on intimacy/spontaneity/libido
Availability Where obtained
Level of sexual activity How frequently having sex
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pearance when added to the figure. In general, efficacy
and side effects/health risks were prominent attributes
in both surveys/interviews and DAs. Several attributes
included in decision aids were not mentioned in sur-
veys/interviews (i.e., needle phobia, post-coital, pre-sex
preparation, postpartum compatibility, alarm signs, reli-
gious considerations).Comparison of surveys/interviews and DAs
While the limited number of resources precludes a
quantitative statistical comparison of how often surveys/
interviews versus DAs included each issue, some tenta-
tive observations can be made. Some issues were
highlighted more often in decision aids compared to sur-
veys/interviews: STI prevention (11 vs. 4), noncontracep-
tive benefits (11 vs. 4), how used (9 vs. 2), cost (6 vs. 2),
# of surveys/interviews
including attribute group 
(out of 20)
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Figure 2 Number of resources including each attribute. Surveys and structured interviews are represented on the left and DAs on the right.
Saturation of all of the boxes one side of midline indicates all resources in that category included the specified attribute.
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woman’s vicarious experience with contraceptive methods
was considered more often in surveys/interviews than de-
cision aids (8 vs. 1).
Discussion
We summarize a number of surveys and decision aids
that uncover which issues women may consider when
choosing a method of contraception. Our results re-
vealed that there are many important attributes women
may consider when choosing among contraceptive
methods and that these attributes are themselves hetero-
geneous in the way they are experienced (and named).
While some tools (e.g., the WHO DMT) have been
rigorously studied, many (in particular, the online tools)
remain unstudied. Given that many women may be
turning to online resources to help them make decisions
about contraception, evaluation of these tools is impera-
tive to ensure that tools address the needs of their users.
It is also imperative that decision making tools are
evidence-based and that intended users are included in
the development process to ensure that relevant attri-
butes are considered. Tools can only be effective if they
address the needs of their users, and in the case of
contraceptive choice, this means addressing the attributes
about methods that matter most to women. However, this
goal sometimes proves elusive, as contraceptive choice is
influenced by a multitude of socio-cultural, geographical,
and personal factors such that a one-size-fits-all approach
may not work. For instance, cost may not be a concern in
areas where contraception is provided at no cost to the
user, and menstrual changes could be seen as a positive ornegative aspect of a contraceptive method, depending on
the user. Moreover, the issues that matter most to a
woman at a given point in her life may be different later
on in life. The diversity of factors that influence contra-
ceptive choice is likely reflected in the heterogeneity of is-
sues included in the resources we reviewed—while some
of the medical issues (e.g., efficacy, STI prevention, side ef-
fects) were almost unanimously included, some more
practical considerations such as the burden of use associ-
ated with the method and socio-cultural attitudes about the
methods were less-often considered.
Indeed, it was striking to see the differences observed
in how frequently and inconsistently many issues were in-
cluded in surveys/interviews compared to DAs. Medical
considerations, such as STI prevention, noncontraceptive
benefits, and requirement of a healthcare provider were
highlighted more often in decision aids compared to sur-
veys/interviews. In contrast, the vicarious experiences of
women were considered in surveys/interviews far more
often than decision aids. While we have no gold standard
to identify the “true” perspective of women, if we assume
that the surveys/interviews reflect the true perspective of
women, the discrepancies observed between attributes in-
cluded in surveys/interviews and DAs suggest that the
true perspectives of users are not being reflected in the
available tools. This is to say that tools may be including
medical issues that women do not consider very import-
ant in lieu of including practical issues that matter to them
more. Alternatively, given that many of the attributes in-
cluded in surveys/interviews were investigator-driven, it is
possible that both the surveys/interviews and DAs both
may be reflective of investigator biases as opposed to what
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ceptive choice is such an individualized process that sur-
veys and decision aids will always show variability in the
issues they include based on who the users are. While it is
clear that all of the issues we listed are important to some
extent, some will be more important than others, and the
relative importance of each will vary from user to user. Fu-
ture decision aids need to keep this in mind and may need
to be tailored to individual populations. Qualitative re-
search within a target population may be useful prior to
implementing a decision aid to ensure that the aid is of
the utmost relevance to its users.
As the issues emphasized in DAs appear to reflect what
providers feel are important to women when choosing a
method of contraception, it remains unclear how providers
influence patients’ choice of contraceptives and whether
provider influence is concordant with patient preference.
An international study of women in the United States and
Europe observed that physicians have the greatest influence
on what type of contraception women choose, with over
half of all women seeking advice from health care profes-
sionals and less seeking this advice from family, friends, or
the internet [46]. Another large study of over 18,000
women demonstrated that nearly half (47%) chose a differ-
ent method than the one they originally planned to choose
after receiving counseling from a health care provider [47].
This highlights the key role that providers play in influen-
cing women’s choice of contraception.
Although patients want their physicians to be involved
in contraception decisions, they want this involvement
in the context of choosing a method that fits their per-
sonal values and preferences [6]. Do recommendations
made by health professionals reflect their own personal
biases or their patients’ true preferences and values? To
examine the role provider preference plays on recom-
mendations they make to patients, an international study
of healthcare providers (over two-thirds of which were
obstetrician-gynecologists) examined providers’ own
choice of contraception, reasons for choice, and if these
choices are concordant with recommendations they
make to patients. The majority of healthcare providers
used an intrauterine device, and most common reasons
for use among these providers included the method
matching their family situation (28%) and contraceptive
efficacy (22.8%). These providers were more likely than
others to recommend the method for patients who have
completed planned childbearing (p < 0.001), and they
were also more likely to not recommend oral contracep-
tives for patients who have not completed their childbear-
ing plans (p = 0.011). This suggests that providers who use
an intrauterine device are more likely to recommend to
patients the method they use in favor of those they do
not, and the reasons providers choose a contraceptive
method may differ from reasons their patients do [48].How do we, then, ensure that tools reflect the needs of
their users (i.e., women)? Certainly, individualizing deci-
sion aids presents challenges. If a decision aid were to
present all 32 unique attributes we list across the ap-
proximately 20 contraceptive methods available, it would
certainly be unwieldy and introduce a heavy cognitive
burden. Computer-based tools are a natural solution to
this problem, as they provide a means to develop modu-
lar and easily-adaptable decision aids. For example, a de-
cision aid could only present the options available to a
woman based on stated preferences (e.g., permanent
sterilization methods can be excluded if she states a
preference for future childbearing) and could present
only the attributes about these methods that a woman
deems important. Indeed, some online tools we reviewed
have taken this approach.
Development of modular tools for low-resource set-
tings, however, produces certain challenges, as cost and
the need for electricity limit use of computer-based deci-
sion aids. In the past, our group has developed decision
aids using an “issue cards” approach, where users are
given several cards, each which highlights a certain attri-
bute about treatment options (e.g., cost, side effects,
how it is used) compares across all of the options available
to the user [49]. In low-resource settings, this design may
be more feasible as the number of contraceptive options
may be limited on the basis of availability. In this case,
cards would only need to include the few options avail-
able, and a card could be generated for each attribute, with
only the most relevant attribute cards being presented to
the woman based on stated or elicited preferences.
Given recent advances in technology, computer-based so-
lutions may not be far out of reach for low-resource settings.
In 2007, Amazon.com introduced the Kindle E-reader. Ini-
tially designed as a book reader and sold for $399 USD, it
featured a “e-ink” display which presents text and graphics
on a screen with minimal glare and ultra-low power usage
[50]. Today, a Kindle retails for $69 USD and can last weeks
on a single charge [51]. The low power usage makes the
device attractive for use in low-resource settings, and the
low-glare screen is beneficial if used outdoors in the sun.
Versions of the Kindle offer global cellular connectivity, per-
mitting for wireless delivery of content to remote locations
[52]. Based on its low cost, the Kindle may be a feasible
computer-based decision aid delivery device for low-
resource settings. To our knowledge, the Kindle has not
been used as a decision aid delivery device before.
Certainly, factors other than the content of a decision
aid will influence whether it is effective. While many of
these aspects have not been formally studied, recent
work from our group [Under review in Implementation
Science] has shown that when providers do not use
decision aids as intended, that providers involve patients
less and knowledge transfer suffers. Therefore, effective
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sion aids may make these tools more effective.
This study has several important limitations. For one,
the degree to which each attribute was deemed import-
ant to women was not included in all studies nor was
the quality of the evidence and risk of bias able to be
assessed, given that unpublished online tools were in-
cluded and these tools were not necessarily subject to
quality control measures. Moreover, the major source of
bias identified was that investigators often selected the
items included on surveys and decision aids. This lim-
ited our ability to prioritize attributes according to rela-
tive importance and quality of evidence but did not
impair our ability to generate a master list and classify
attributes from which women might choose the most
pertinent and important to them. Future meta-analysis
could attempt to summarize how important women
deem each attribute in relation to others to understand
general trends, realizing that these preferences vary from
woman to woman. The search strategy and extraction
process also had several limitations, including that the
search strategy did not provide a means for including
paper-based decision aids that were not published in aca-
demic journals, the online search for “gray literature” was
not systematic (and could have been affected by selection
bias), and additionally, only 10% of data was extracted by
2 people independently. Strengths included the systematic
search and duplicate study selection process.
Overall, contraceptive choice is a complex decision,
marked with multiple considerations that must be care-
fully deliberated across an assortment of options. More-
over, the attributes that matter most differ from woman
to woman based on individual context and may change
for a given woman over time. Given the complexity of
this decision, DAs might help women choose birth control
methods that fit their values, needs and preferences.
Ideally, if women find methods that fit their needs, values
and preferences, this will lower rates of inconsistent use
and nonuse and limit unintended pregnancies. While
many DAs exist, they remain poorly studied, and aspects
of effective DAs for contraceptive choice (including the at-
tributes of methods that should be included) remain un-
clear. Here, we provide a framework for future DA
development that takes into account attributes that may
be considered when choosing a method of contraception
and gives consideration for low-resource settings.
Conclusions
Many attributes were identified as potentially important
to women choosing a method of contraception, but
these were inconsistently included in the reviewed re-
sources, perhaps reflecting the individualized nature of
contraceptive choice. Decision aids should be tailored to
include the attributes that are most important to users.Additional resources
Readers interested in the community-level version of the
WHO DMT may find it at http://www.who.int/reproductive
health/publications/family_planning/9789241503754/en/
index.html. WHO also publishes a decision making tool for
people living with HIV that can be found online: http://
www.who.int/reproductivehealth/publications/family_
planning/9241595132/en/index.html.Additional files
Additional file 1: Sample search strategies.
Additional file 2: Details extracted from published studies
regarding the process for designing decision aids, when reported.
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